TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT04917887: Long-Term Follow-up Protocol

Sponsor: Krystal Biotech, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 50 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$398,400

Rescue Site Savings

+$265,600

Unlock Full NCT04917887 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04917887 Rescue Dossier →